Intensive voice treatment (LSVT ®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus

Journal of Communication Disorders

Volumn 44, Issue 6, 2011, Pages 688-700

  Spielman, Jennifer ^a,c   Mahler, Leslie ^b   Halpern, Angela ^a,c   Gilley, Phllip ^c   Klepitskaya, Olga ^d   Ramig, Lorraine ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Behavioral treatment; Deep brain stimulation; Dysarthria; LSVT ; Parkinson's disease; Subthalamic nucleus

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE VOICE THERAPY; MALE; PARKINSON DISEASE; SOUND PRESSURE; SPEECH ANALYSIS; SPEECH ARTICULATION; SPEECH THERAPY; STRUCTURED INTERVIEW; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; VOICE; VOICE HANDICAP INDEX; VOICE INTENSITY; VOWEL ARTICULATION INDEX;

AGED; AGED, 80 AND OVER; DEEP BRAIN STIMULATION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PARKINSON DISEASE; SPEECH DISORDERS; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; VOICE TRAINING;

EID: 80755153261     PISSN: 00219924     EISSN: 18737994     Source Type: Journal    
DOI: 10.1016/j.jcomdis.2011.05.003     Document Type: Article

References (74)

1. Ball L.J., Beukelman D.R., Pattee G.L. Communication effectiveness of individuals with amyotrophic lateral sclerosis. Journal of Communication Disorders 2004, 37(3):197-215.
2. Baumgartner C.A., Sapir S., Ramig T.O. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease. Journal of Voice 2001, 15(1):105-114.
3. Baylor C.R., Yorkston K.M., Eadie T.L., Miller R.M., Amtmann D. Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample. Journal of Speech, Language, and Hearing Research 2009, 52(5):1302-1320.
4. Beck A., Steer R., Brown G. Beck Depression Inventory(R)-II 1996, Pearson Education, Inc., San Antonio, TX.
5. Cohen J. Statistical power analysis for the behavioral sciences 1988, Erlbaum, Hillsdale, NJ. 2nd ed.
6. Countryman S., Ramig L., Pawlas A. Speech and voice deficits in Parkinsonian Plus Syndromes: Can they be treated?. Journal of Medical Speech-Language Pathology 1994, 2(3):211-225.
7. D'Alatri L., Paludetti G., Contarino M.F., Galla S., Marchese M.R., Bentivoglio A.R. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. Journal of Voice 2008, 22(3):365-372.
8. Darley F., Aronson A., Brown J. Motor speech disorders 1975, Saunders, Philadelphia.
9. Dromey C., Kumar R., Lang A.E., Lozano A.M. An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Movement Disorders 2000, 15(6):1132-1138.
10. El-Sharkawi A., Ramig L., Logemann J.A., Pauloski B.R., Rademaker A.W., Smith C.H., et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): A pilot study. Journal of Neurology, Neurosurgery, and Psychiatry 2002, 72(1):31-36.
11. Fairbanks G. Voice and articulation drillbook 1960, Harper & Brothers, New York.
12. Forrest K., Weismer G., Turner G.S. Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults. Journal of the Acoustical Society of America 1989, 85(6):2608-2622.
13. Fox C, Ramig L. Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. American Journal of Speech-Language Pathology 1997, 6:85-94.
14. Fox C.M., Ramig L.O., Ciucci M.R., Sapir S., McFarland D.H., Farley B.G. The science and practice of LSVT/LOUD: Neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Seminars in Speech and Language 2006, 27(4):283-299.
15. Gentil M., Garcia-Ruiz P., Pollak P., Benabid A.L. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism. European Neurology 2000, 44(3):147-152.
16. Halpern A., Spielman J., Ramig L., Sharpley A., Panzer I. The effects of loudness and noise on speech intelligibility in Parkinson disease. Presented at 14th biennial conference on motor speech 2008.
17. Hammer M.J., Barlow S.M., Lyons K.E., Pahwa R. Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson's disease. Journal of Neurology 2010, 257(10):1692-1702.
18. Hammer M.J., Barlow S.M., Lyons K.E., Pahwa R. Subthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease. Journal of Communication Disorders 2011, 44(1):37-48.
19. Hartelius L., Svensson P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: A survey. Folia Phoniatrica et Logopaedica 1994, 46(1):9-17.
20. Hintze J. NCSS (Version NCSS 2007) [Computer software] 2007, NCSS, LLC, Kaysville, UT.
21. Ho A.K., Bradshaw J.L., Iansek R. For better or worse: The effect of levodopa on speech in Parkinson's disease. Movement Disorders 2008, 23(4):574-580.
22. Ho A.K., Iansek R., Marigliani C., Bradshaw J.L., Gates S. Speech impairment in a large sample of patients with Parkinson's disease. Behavioral Neurology 1998, 11(3):131-137.
23. Hoehn M.M., Yahr M.D. Parkinsonism: Onset, progression and mortality. Neurology 1967, 17(5):427-442.
24. Holmes R.J., Oates J.M., Phyland D.J., Hughes A.J. Voice characteristics in the progression of Parkinson's disease. International Journal of Language & Communication Disorders 2000, 35(3):407-418.
25. Iulianella I., Adams S.G., Gow A.K. Effects of sub-thalamic deep brain stimulation on speech production in Parkinson's Disease: A critical review of the literature. Canadian Journal of Speech-Language Pathology & Audiology 2008, 32(2):85-91.
26. Jacobson B., Johnson A., Grywalski C., Silbergleit J., Jacobson G., Benninger M., et al. The Voice Handicap Index (VHI): Development and validation. American Journal of Speech-Language Pathology 1997, 6(3):66-70.
27. Jones H.N., Kendall D.L., Sudhyadhom A., Rosenbek J.C. The effects of lesion therapy and deep brain stimulation on speech function in patients with Parkinson's disease. Communicative Disorders Review 2007, 1(3-4):133-173.
28. Kleim J.A., Jones T.A. Principles of experience-dependent neural plasticity: Implications for rehabilitation after brain damage. Journal of Speech, Language, and Hearing Research 2008, 51(1):S225-S239.
29. Klostermann F., Ehlen F., Vesper J., Nubel K., Gross M., Marzinzik F., et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2008, 79(5):522-529.
30. Liotti M., Ramig L.O., Vogel D., New P., Cook C.I., Ingham R.J., et al. Hypophonia in Parkinson's disease: Neural correlates of voice treatment revealed by PET. Neurology 2003, 60(3):432-440.
31. Logemann J.A., Fisher H.B., Boshes B., Blonsky E.R. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. Journal of Speech and Hearing Disorders 1978, 43(1):47-57.
32. ®LOUD on four participants with Parkinson disease who received deep brain stimulation of the subthalamic nucleus. Presented at 12th international congress of Parkinson's disease and movement disorders 2008.
33. Matos C. SPL extractor [Computer software] 2003, Salvador, Brazil.
34. Milenkovic P. TF32 [Computer software] 2004.
35. Miller N., Allcock L., Jones D., Noble E., Hildreth A.J., Burn D.J. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2007, 78(11):1188-1190.
36. Miller N., Noble E., Jones D., Burn D. Life with communication changes in Parkinson's disease. Age and Ageing 2006, 35(3):235-239.
37. Narayana S, Fox P.T., Zhang W., Franklin C., Robin D.A., Vogel D., et al. Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis. Human Brian Mapping 2010, 31(2):222-236.
38. Narayana S., Jacks A., Robin D.A., Poizner H., Zhang W., Franklin C., et al. A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's disease. American Journal of Speech-Language Pathology 2009, 18(2):146-161.
39. Pinto S., Ozsancak C., Tripoliti E., Thobois S., Limousin-Dowsey P., Auzou P. Treatments for dysarthria in Parkinson's disease. Lancet Neurology 2004, 3(9):547-556.
40. Pinto S., Thobois S., Costes N., Le B.D., Benabid A.L., Broussolle E. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: A PET study. Brain 2004, 127(Pt 3):602-615.
41. Ramig L.O., Countryman S., Thompson L.L., Horii Y. Comparison of two forms of intensive speech treatment for Parkinson disease. Journal of Speech and Hearing Research 1995, 38(6):1232-1251.
42. Ramig L.O., Sapir S., Countryman S., Pawlas A.A., O'Brien C., Hoehn M. Intensive voice treatment (LSVT) for patients with Parkinson's disease: A 2 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry 2001, 71(4):493-498.
43. Ramig L.O., Sapir S., Fox C., Countryman S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: A comparison with untreated patients and normal age-matched controls. Movement Disorders 2001, 16(1):79-83.
44. Rosen K.M., Kent R.D., Delaney A.L., Duffy J.R. Parametric quantitative acoustic analysis of conversation produced by speakers with dysarthria and healthy speakers. Journal of Speech Language, and Hearing Research 2006, 49(2):395-411.
45. Rousseaux M., Krystkowiak P., Kozlowski O., Ozsancak C., Blond S., Destee A. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. Journal of Neurology 2004, 251(3):327-334.
46. Roy N., Nissen S.L., Dromey C., Sapir S. Articulatory changes in muscle tension dysphonia: Evidence of vowel space expansion following manual circumlaryngeal therapy. Journal of Communication Disorders 2009, 42(2):124-135.
47. Santens P., De Letter M., Van Borsel J., De Reuck J., Caemaert J. Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson's disease. Brain and Language 2003, 87(2):253-258.
48. Sapir S. Vowel Articulation Index as a robust acoustic index of dysarthric vowel articulation: Evidence from the speech of individuals with and without idiopathic Parkinson's disease. Presented at the annual conference of the Israeli Association of Physical and Rehabilitation Medicine 2007.
49. Sapir S., Ramig L.O., Hoyt P., Countryman S., O'Brien C., Hoehn M. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: A comparison with an alternative speech treatment. Folia Phoniatrica et Logopaedica 2002, 54(6):296-303.
50. Sapir S., Ramig L.O., Spielman J.L., Fox C. Formant centralization ratio: A proposal for a new acoustic measure of dysarthric speech. Journal of Speech Language, and Hearing Research 2010, 53(1):114-125.
51. Sapir S., Spielman J., Ramig L.O., Hinds S.L., Countryman S., Fox C., et al. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: A case study. American Journal of Speech-Language Pathology 2003, 12(4):387-399.
52. Sapir S., Spielman J.L., Ramig L.O., Story B.H., Fox C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual findings. Journal of Speech Language, and Hearing Research 2007, 50(4):899-912.
53. Sarno M.T. Speech impairment in Parkinson's disease. Archives of Physical Medicine and Rehabilitation 1968, 49(5):269-275.
54. Schulz G.M. The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: A review of the literature. Current Medicinal Chemistry 2002, 9(14):1359-1366.
55. Skodda S., Visser W., Schlegel U. Vowel articulation in Parkinson's disease. Journal of Voice 2010.
56. Solomon N.P., Hixon T.J. Speech breathing in Parkinson's disease. Journal of Speech and Hearing Research 1993, 36(2):294-310.
57. Spielman J.L., Borod J.C., Ramig L.O. The effects of intensive voice treatment on facial expressiveness in Parkinson disease: Preliminary data. Cognitive and Behavioral Neurology 2003, 16(3):177-188.
58. Spielman J., Gilley P., Halpern A., Ramig L. Relationship of communicative effectiveness to voice handicap, acoustics, and behavioral characteristics in people with Parkinson disease. Presented at 15th biennial conference on motor speech 2010.
59. ® following deep brain stimulation of the subthalamic nucleus: Preliminary findings. Presented at 13th biennial conference on motor speech 2006.
60. Svec J.G, Popolo P.S., Titze I.R. Measurement of vocal doses in speech: Experimental procedure and signal processing. Logopedics, Phoniatrics, Vocology 2003, 28(4):181-192.
61. Tjaden K., Wilding G.E. Rate and loudness manipulations in dysarthria: Acoustic and perceptual findings. Journal of Speech, Language, and Hearing Research 2004, 47(4):766-783.
62. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders 2010, 25(15):2649-2653.
63. Tornqvist A.L., Schalen L., Rehncrona S. Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation. Movement Disorders 2005, 20(4):416-423.
64. Tripoliti E., Limousin-Dowsey P., Tisch S., Borrell E., Hariz M.L. Speech in Parkinson's disease following subthalamic nucleus deep brain stimulation: Preliminary results. Journal of Medical Speech-Language Pathology 2006, 14:309-325.
65. Tripoliti E., Zrinzo L., Martinez-Torres I., Frost E., Pinto S., Foltynie T., et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 2011, 76(1):80-86.
66. Tripoliti E., Zrinzo L., Martinez-Torres I., Tisch S., Frost E., Borrell E., et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Movement Disorders 2008, 23(16):2377-2383.
67. Walker H.C., Phillips D.E., Boswell D.B., Guthrie B.L., Guthrie S.L., Nicholas A.P., et al. Relief of acquired stuttering associated with Parkinson's disease by unilateral left subthalamic brain stimulation. Journal of Speech, Language, and Hearing Research 2009, 52(6):1652-1657.
68. Walshe M., Peach R.K., Miller N. Dysarthria impact profile: Development of a scale to measure psychosocial effects. International Journal of Language & Communication Disorders 2009, 44(5):693-715.
69. Wang E., Verhagen M.L., Bakay R., Arzbaecher J., Bernard B. The effect of unilateral electrostimulation of the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson's disease-A preliminary report. Clinical Linguistics and Phonetics 2003, 17(4-5):283-289.
70. Wang E.Q., Verhagen Metman L., Bakay R.A.E., Arzbaecher J., Bernard B., Corcos D.M. Hemispheric-specific effects of subthalamic nucleus deep brain stimulation on speaking rate and articulatory accuracy of syllable repetitions in Parkinson's disease. Journal of Medical Speech-Language Pathology 2006, 14:323-333.
71. Weismer G., Jeng J.Y., Laures J.S., Kent R.D., Kent J.F. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders. Folia Phoniatrica et Logopaedica 2001, 53(1):1-18.
72. Wenke R.J., Theodoros D., Cornwell P. The short- and long-term effectiveness of the LSVT for dysarthria following TBI and stroke. Brain Injury 2008, 22(4):339-352.
73. Yorkston K.M., Beukelman D.R. Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate. Journal of Speech and Hearing Disorders 1981, 46(3):296-301.
74. Yorkston K.M., Spencer K.A., Duffy J.R. Behavioral management of respiratory/phonatory dysfunction from dysarthria: A systematic review of the evidence. Journal of Medical Speech-Language Pathology 2003, 11(2):12-38.